ABSTRACT
Garlic has attracted considerable attention because of its bactericidal and anticancer effects. However, the greening of garlic purees greatly affects the product quality. This study investigated the influence of light colors and power on the greening of garlic, and determined the key substances of garlic puree greening, including γ-glutamyl transpeptidase (γ-GT), thiosulfinate, and alliinase. Results showed that purple light source greatly affects greening power, γ-GT, and thiosulfinate. Illumination using a 3-W power lamp could reduce the production of thiosulfinate and alliinase and inhibit the green transformation reaction. Illumination using a 5-W power lamp greatly affected the thiosulfinate content and greening power, whereas that using a 7-W power lamp greatly influenced the γ-GT activity, porphobilinogen content, and alliinase content. Results showed that the green color of garlic puree is greatly affected by the illumination color and intensity, which provides theoretical support for the anti-greening of light garlic puree. PRACTICAL APPLICATION: Because garlic puree easily turns green during processing, which affects the product quality and economic value, this study uses controllable light source radiation to influence the greening of garlic puree, hoping to delay or even solve this problem and provide a new simple method to prevent garlic puree from turning greening.
Subject(s)
Carbon-Sulfur Lyases/metabolism , Garlic/enzymology , Garlic/radiation effects , Plant Proteins/metabolism , gamma-Glutamyltransferase/metabolism , Color , Garlic/chemistry , Garlic/growth & development , Light , Pigments, Biological/analysis , Pigments, Biological/metabolism , Porphobilinogen/analysis , Porphobilinogen/metabolismABSTRACT
BACKGROUND: Acute intermittent porphyria (AIP) is caused by diminished activity of porphobilinogen deaminase (PBGD). The purpose of this study was to validate and compare two assays for PBGD activity. The clinical sensitivity of the PBGD activity assays in AIP diagnosis was also evaluated. METHODS: This study included 74 subjects from 18 Taiwanese families including symptomatic patients with AIP, asymptomatic carriers, and healthy family members. The specific mutations in AIP patients were identified by DNA sequencing. PBGD activity was measured in erythrocytes by quantifying formation of coproporphyrin or uroporphyrin by the enzyme using porphobilinogen (PBG) as a substrate and fluorimetry for detection. RESULTS: The calibration curves obtained with pure coproporphyrin or uroporphyrin were linear with correlation coefficients >0.99 in the range of 0-200nM for coproporphyrin and 0-150nM for uroporphyrin. The coefficients of variation for within-run and between-day imprecision were <9.8% for both assays. The three groups of subjects were used to establish the best cut-off of PBGD activity for identifying symptomatic AIP patients by using area under receiver operating characteristic curve analysis. The symptomatic AIP patients and asymptomatic carriers had significantly lower PBGD activity compared with the healthy family members (all p<.001). CONCLUSION: Two different PBGD activity assays were validated. The best cut-off for coproporphyrin was derived as 46.4nmol/h/mL RBC with corresponding sensitivity of 100% and specificity of 100% and the best cut-off for uroporphyrin was derived as 43.7nkat/L RBC with corresponding sensitivity of 100% and specificity of 97.4%.
Subject(s)
Hydroxymethylbilane Synthase/metabolism , Porphyria, Acute Intermittent/diagnosis , Adolescent , Adult , Aged , Child , DNA/analysis , Female , Fluorometry , Hematocrit , Hemoglobins/analysis , Humans , Hydroxymethylbilane Synthase/blood , Hydroxymethylbilane Synthase/genetics , Male , Middle Aged , Molecular Structure , Mutation , Porphobilinogen/analysis , Porphobilinogen/metabolism , Porphyria, Acute Intermittent/blood , Porphyria, Acute Intermittent/metabolism , Substrate Specificity , Taiwan , Young AdultABSTRACT
The diverse gut microbial communities are crucial for host health. How the interactions between microbial communities and between host and microbes influence the host, however, is not well understood. To facilitate gut microbiota research, selective imaging of specific groups of microbiotas in the gut is of great utility but remains technically challenging. Here we present a chemical approach that enables selective imaging of Gram-negative and Gram-positive microbiotas in the mouse gut by exploiting their distinctive cell wall components. Cell-selective labeling is achieved by the combined use of metabolic labeling of Gram-negative bacterial lipopolysaccharides with a clickable azidosugar and direct labeling of Gram-positive bacteria with a vancomycin-derivatized fluorescent probe. We demonstrated this strategy by two-color fluorescence imaging of Gram-negative and Gram-positive gut microbiotas in the mouse intestines. This chemical method should be broadly applicable to different gut microbiota research fields and other bacterial communities studied in microbiology.
Subject(s)
Diagnostic Techniques, Digestive System , Dysbiosis/diagnostic imaging , Gastrointestinal Microbiome , Gastrointestinal Tract/diagnostic imaging , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Animals , Azides/analysis , Azides/chemistry , Azides/metabolism , Azides/pharmacology , Carbocyanines/analysis , Cell Wall/chemistry , Click Chemistry , Dysbiosis/microbiology , Fluorescent Dyes/analysis , Fluorescent Dyes/chemistry , Fluorescent Dyes/metabolism , Fluorescent Dyes/pharmacology , Gastrointestinal Tract/microbiology , Gram-Negative Bacteria/cytology , Gram-Negative Bacteria/growth & development , Gram-Negative Bacteria/metabolism , Gram-Positive Bacteria/cytology , Gram-Positive Bacteria/growth & development , Gram-Positive Bacteria/metabolism , Lipopolysaccharides/analysis , Lipopolysaccharides/biosynthesis , Lipopolysaccharides/chemistry , Mice, Inbred C57BL , Microbial Viability/drug effects , Optical Imaging , Pilot Projects , Porphobilinogen/analogs & derivatives , Porphobilinogen/analysis , Porphobilinogen/chemistry , Rhodamines/analysis , Rhodamines/chemistry , Specific Pathogen-Free Organisms , Sugar Acids/analysis , Sugar Acids/chemistry , Sugar Acids/metabolism , Sugar Acids/pharmacology , Vancomycin/analogs & derivatives , Vancomycin/analysisABSTRACT
Direct cell-to-cell transmission of proteopathic α-synuclein (α-syn) aggregates is thought to underlie the progression of neurodegenerative synucleinopathies. However, the specific intracellular processes governing this transmission remain unclear because currently available model systems are limited. For example, in cell culture models of α-syn-seeded aggregation, it is difficult to discern intracellular from extracellular exogenously applied α-syn seed species. Herein, we employed fluorescently labeled α-syn preformed fibrils (pffs) in conjunction with the membrane-impermeable fluorescence quencher trypan blue to selectively image internalized α-syn seeds in cultured primary neurons and to quantitatively characterize the concentration dependence, time course, and inhibition of pff uptake. To study the long-term fates of exogenous α-syn pffs in neurons, we developed a pff species labeled at amino acid residue 114 with the environmentally insensitive fluorophore BODIPY or the pH-sensitive dye pHrodo red. We found that pffs are rapidly trafficked along the endolysosomal pathway, where most of the material remains for days. We also found that brief pharmacological perturbation of lysosomes shortly after the pff treatment causes aberrations in intracellular processing of pff seeds concomitant with an increased rate of inclusion formation via recruitment of endogenous α-syn to a relatively small number of exogenous seeds. Our results validate a quantitative assay for pff uptake in primary neurons, implicate lysosomal processing as the major fate of internalized proteopathic seeds, and suggest lysosomal integrity as a significant rate-determining step in the transmission of α-syn pathology. Further, lysosomal processing of transmitted seeds may represent a new therapeutic target to combat the spread of synucleinopathies.
Subject(s)
Endosomes/metabolism , Hippocampus/metabolism , Lysosomes/metabolism , Neurons/metabolism , Protein Aggregation, Pathological/metabolism , alpha-Synuclein/metabolism , Amino Acid Substitution , Animals , Cells, Cultured , Coloring Agents/analysis , Embryo, Mammalian/cytology , Endocytosis , Endosomes/pathology , Endosomes/ultrastructure , Fluorescent Dyes/analysis , Fluorescent Dyes/chemistry , Green Fluorescent Proteins/chemistry , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Hippocampus/pathology , Hippocampus/ultrastructure , Humans , Hydrogen-Ion Concentration , Lysosomes/pathology , Lysosomes/ultrastructure , Mice , Microscopy, Electron, Transmission , Mutation , Neurons/pathology , Neurons/ultrastructure , Porphobilinogen/analogs & derivatives , Porphobilinogen/analysis , Porphobilinogen/chemistry , Protein Aggregation, Pathological/pathology , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Rhodamines/analysis , Rhodamines/chemistry , Trypan Blue/analysis , alpha-Synuclein/chemistry , alpha-Synuclein/geneticsABSTRACT
Fundamento y objetivos: La porfiria aguda intermitente (PAI) es una enfermedad causada por un defecto en la enzima porfobilinógeno deaminasa que cataliza la tercera etapa de síntesis del hemo. Los portadores pueden presentar ataques neuroviscerales agudos tras sobreproducción hepática de precursores del hemo. Pacientes y método: Se presentan las características de todos los pacientes con PAI atendidos en el Hospital Clínic de Barcelona entre los años 1993-2013, y su seguimiento a largo plazo. Resultados: Treinta y cinco pacientes con PAI (33 mujeres y 2 varones) presentaron ataques agudos neuroviscerales. El tratamiento con hemina resolvió el cuadro agudo en todos los casos. Nueve pacientes presentaron polineuropatía y secuelas persistentes. El seguimiento permitió clasificar a los pacientes en: A, con sintomatología aguda durante 1-2 años y posterior remisión duradera (n = 24) o bien alguna crisis puntual (n = 3), y B, con ataques recurrentes que requirieron administración crónica de hemina (n = 8). En la mayoría de los pacientes del grupo A la concentración urinaria de precursores del hemo fue disminuyendo progresivamente, mientras que en el grupo B esta se mantuvo elevada sin descenso observable a largo término. Adicionalmente, el estudio familiar permitió identificar 44 portadores asintomáticos, la mayoría (70,5%) con valores normales de precusores del hemo en orina. Conclusiones: Una mayoría de pacientes con PAI de nuestra serie logró una remisión clínica duradera. Una minoría presenta ataques recurrentes, sin que el tratamiento crónico con hemina haga factible su interrupción ni induzca remisión bioquímica a largo plazo. El tipo de mutación en el gen de la porfobilinógeno deaminasa, y también factores asociados al estilo de vida, pueden determinar el curso de la remisión (AU)
Background and objectives: Acute intermittent porphyria (AIP) is a rare disease that results from a deficiency of porphobilinogen deaminase, the third enzyme of the heme biosynthetic pathway. AIP carriers are at risk of presenting acute neurovisceral attacks associated with overproduction of heme-precursors in the liver. Patients and method: We report the characteristics of all AIP patients attended in the Hospital Clinic of Barcelona during the years 1993-2013 and their long-term follow-up. Results: Thirty-five AIP patients (33 women, 2 men) experienced acute attacks. Treatment with hemin resolved the acute neurovisceral crisis in all cases. Nine patients presented peripheral neuropathy and persistent sequelae. Long-term follow-up allowed classifying the patients into groups: A, patients with acute symptoms during 1-2 years and subsequent long-lasting clinical remission (n = 24) or a few sporadic crises (n = 3), and B, patients with recurrent attacks requiring chronic administration of hemin (n = 8). In a majority of the patients of group A, the urinary excretion of heme-precursors decreased gradually over time. However, the chronic hemin regime did not induce a decline of urinary heme-precursors in the patients of group B. Additionally, we identified 44 asymptomatic AIP carriers, most (70.5%) with normal values of heme-precursors in urine. Conclusions: A majority of the AIP patients of our series achieved a long-lasting clinical remission. A minority (23%) presented recurrent attacks that required chronic hemin infusions without feasible interruption and without long-term biochemical remission. The type of mutation within the porphobilinogen deaminase gene and also life-style related factors may determine remission time-course (AU)
Subject(s)
Adolescent , Adult , Female , Humans , Male , Middle Aged , Porphyria, Acute Intermittent/genetics , Porphyria, Acute Intermittent/physiopathology , Porphyria, Acute Intermittent , Porphobilinogen/analysis , Porphobilinogen , Mutagenesis/genetics , Follow-Up Studies , Hemin , Hemin/isolation & purification , Abdominal Pain/complications , Abdominal Pain/etiology , Nausea/complications , Paresis/complications , Hyponatremia/complications , Life StyleABSTRACT
Antibiotic resistance (AR) is increasingly prevalent in low and middle income countries (LMICs), but the extent of the problem is poorly understood. This lack of knowledge is a critical deficiency, leaving local health authorities essentially blind to AR outbreaks and crippling their ability to provide effective treatment guidelines. The crux of the problem is the lack of microbiology laboratory capacity available in LMICs. To address this unmet need, we demonstrate a rapid and simple test of ß -lactamase resistance (the most common form of AR) that uses a modified ß -lactam structure decorated with two fluorophores quenched due to their close proximity. When the ß -lactam core is cleaved by ß -lactamase, the fluorophores dequench, allowing assay speeds of 20 min to be obtained with a simple, streamlined protocol. Furthermore, by testing in competition with antibiotics, the ß -lactamase-associated antibiotic susceptibility can also be extracted. This assay can be easily implemented into standard lab work flows to provide near real-time information of ß -lactamase resistance, both for epidemiological purposes as well as individualized patient care.
Subject(s)
Bacteria/enzymology , Fluorescent Dyes/chemistry , Spectrometry, Fluorescence/methods , beta-Lactam Resistance , beta-Lactamases/analysis , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Bacteriological Techniques/methods , Fluorescent Dyes/analysis , Fluorescent Dyes/metabolism , Molecular Probe Techniques , Porphobilinogen/analogs & derivatives , Porphobilinogen/analysis , Porphobilinogen/chemistry , Porphobilinogen/metabolism , beta-Lactamases/metabolism , beta-Lactams/pharmacologyABSTRACT
RATIONALE: Human porphyrias, diseases caused by enzyme defects in haem biosynthesis, are characterised by the excessive production, accumulation and excretion of porphyrins and/or 5-aminolaevulinic acid (ALA) and porphobilinogen (PBG). A method for the simultaneous separation, detection and identification of ALA, PBG and porphyrins would greatly facilitate the screening and diagnosis of porphyrias. Such a method would also be invaluable for the biochemical study of the haem, chlorophyll and corrin pathways. METHODS: An aqueous mixture containing ALA, PBG and type I isomer porphyrins was diluted with acetonitrile and infused (10 µL/min) into a Waters Synapt G2 high-definition mass spectrometer, equipped with a Z-Spray electrospray ionisation (ESI) source. Mass spectra were acquired in positive ionisation mode and the optimised ion mobility spectrometry (IMS) conditions were as follows: IMS wave height (V), 40; IMS wave velocity (m/s), 648; IMS gas flow (mL/min) 90.40; helium gas flow (mL/min), 182.60. RESULTS: The IMS drift-time increased with increasing ion mass in the order of ALA, PBG, mesoporphyrin, coproporphyrin I, penta-, hexa- and heptacarboxylic acid porphyrin I and uroporphyrin I. The ESI-IMS-MS spectra shows that PBG could form two different positively charged ions by protonation [M+H](+) , m/z 227, or deprotonation [M - H](+) , m/z 225. The protonated PBG (m/z 227) easily eliminated ammonia in source and the fragment ion (m/z 210) was monitored instead. Doubly charged ions of porphyrins having different drift times from the protonated singly charged molecules were observed in high abundance, providing further structural characterisation. CONCLUSIONS: We have shown, for the first time, an analytical method capable of simultaneously separating haem biosynthetic intermediates and metabolites, for a potential rapid clinical screening method for the porphyrias. IMS-MS allowed the separation of doubly charged porphyrin ions, which will be advantageous for the analysis of natural and synthetic tetrapyrrole compounds, while reducing the misinterpretation of contaminants.
Subject(s)
Aminolevulinic Acid/analysis , Porphobilinogen/analysis , Porphyrins/analysis , Spectrometry, Mass, Electrospray Ionization/methods , Aminolevulinic Acid/isolation & purification , Porphobilinogen/isolation & purification , Porphyrins/isolation & purification , Tandem Mass SpectrometryABSTRACT
Oxidative modification of LDL is an early pathological event in the development of atherosclerosis. Oxidation events such as malondialdehyde (MDA) formation may produce specific, immunogenic epitopes. Indeed, antibodies to MDA-derived epitopes are widely used in atherosclerosis research and have been demonstrated to enable cardiovascular imaging. In this study, we engineered a transgenic zebrafish with temperature-inducible expression of an EGFP-labeled single-chain human monoclonal antibody, IK17, which binds to MDA-LDL, and used optically transparent zebrafish larvae for imaging studies. Feeding a high-cholesterol diet (HCD) supplemented with a red fluorescent lipid marker to the transgenic zebrafish resulted in vascular lipid accumulation, quantified in live animals using confocal microscopy. After heat shock-induced expression of IK17-EGFP, we measured the time course of vascular accumulation of IK17-specific MDA epitopes. Treatment with either an antioxidant or a regression diet resulted in reduced IK17 binding to vascular lesions. Interestingly, homogenates of IK17-EGFP-expressing larvae bound to MDA-LDL and inhibited MDA-LDL binding to macrophages. Moreover, sustained expression of IK17-EGFP effectively prevented HCD-induced lipid accumulation in the vascular wall, suggesting that the antibody itself may have therapeutic effects. Thus, we conclude that HCD-fed zebrafish larvae with conditional expression of EGFP-labeled oxidation-specific antibodies afford an efficient method of testing dietary and/or other therapeutic antioxidant strategies that may ultimately be applied to humans.
Subject(s)
Blood Vessels/metabolism , Cholesterol, Dietary/pharmacokinetics , Disease Models, Animal , Hypercholesterolemia/metabolism , Lipoproteins, LDL/metabolism , Malondialdehyde/analogs & derivatives , Microscopy, Confocal/methods , Microscopy, Fluorescence/methods , Zebrafish Proteins/metabolism , Zebrafish/metabolism , Animals , Animals, Genetically Modified , Antibodies, Monoclonal/genetics , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/therapeutic use , Anticholesteremic Agents/therapeutic use , Drug Evaluation, Preclinical , Epitopes/immunology , Genes, Reporter , Green Fluorescent Proteins/analysis , Green Fluorescent Proteins/genetics , Humans , Hydrazines/analysis , Hypercholesterolemia/drug therapy , Hypercholesterolemia/therapy , Immunoglobulin Fab Fragments/genetics , Lipoproteins, LDL/immunology , Macrophages/metabolism , Macrophages/ultrastructure , Malondialdehyde/immunology , Malondialdehyde/metabolism , Oxidation-Reduction , Porphobilinogen/analogs & derivatives , Porphobilinogen/analysis , Probucol/therapeutic use , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/therapeutic use , Single-Chain Antibodies/genetics , Single-Chain Antibodies/immunology , Single-Chain Antibodies/therapeutic use , Temperature , Veins/metabolism , Zebrafish/genetics , Zebrafish/growth & development , Zebrafish Proteins/immunologyABSTRACT
Tetrapyrroles and carotenoids are required for many indispensable functions in photosynthesis. Tetrapyrroles are essential metabolites for photosynthesis, redox reaction, and detoxification of reactive oxygen species and xenobiotics, while carotenoids function as accessory pigments, in photoprotection and in attraction to animals. Their branched metabolic pathways of synthesis and degradation are tightly controlled to provide adequate amounts of each metabolite (carotenoids/tetrapyrroles) and to prevent accumulation of photoreactive intermediates (tetrapyrroles). Many Arabidopsis mutants and transgenic plants have been reported to show variations in steady-state levels of tetrapyrrole intermediates and contents of different carotenoid species. It is a challenging task to determine the minute amounts of these metabolites to assess the metabolic flow and the activities of both pigment-synthesising and degrading pathways, to unravel limiting enzymatic steps of these biosynthetic pathways, and to characterise mutants with accumulating intermediates. In this chapter, we present a series of methods to qualify and quantify anabolic and catabolic intermediates of Arabidopsis tetrapyrrole metabolism, and describe a common method for quantification of different plant carotenoid species. Additionally, we introduce two methods for quantification of non-covalently bound haem. The approach of analysing steady-state levels of tetrapyrrole intermediates in plants, when applied in combination with analyses of transcripts, proteins, and enzyme activities, enables the biochemical and genetic elucidation of the tetrapyrrole pathway in wild-type plants, varieties, and mutants. Steady-state levels of tetrapyrrole intermediates are only up to 1/1,000 of the amounts of the accumulating end-products, chlorophyll, and haem. Although present in very low amounts, the accumulation and availability of tetrapyrrole intermediates have major consequences on the physiology and activity of chloroplasts due to their additional photoreactive and possible signalling functions. Although adjusted for Arabidopsis tetrapyrrole metabolites, the presented methods can also be applied for analysis of cyanobacterial and other plant tetrapyrroles.
Subject(s)
Arabidopsis/metabolism , Chemistry Techniques, Analytical/methods , Photosynthesis , Pigments, Biological/biosynthesis , Tetrapyrroles/biosynthesis , Aminolevulinic Acid/analysis , Aminolevulinic Acid/isolation & purification , Aminolevulinic Acid/metabolism , Apoenzymes/metabolism , Calibration , Carotenoids/analysis , Carotenoids/biosynthesis , Carotenoids/isolation & purification , Chlorophyllides/analysis , Chlorophyllides/biosynthesis , Chlorophyllides/isolation & purification , Chromatography, High Pressure Liquid , Chromatography, Ion Exchange , Heme/analysis , Heme/isolation & purification , Horseradish Peroxidase/metabolism , Pigments, Biological/analysis , Pigments, Biological/isolation & purification , Porphobilinogen/analysis , Porphobilinogen/isolation & purification , Porphobilinogen/metabolism , Protochlorophyllide/analysis , Protochlorophyllide/biosynthesis , Protochlorophyllide/isolation & purification , Spectrometry, FluorescenceABSTRACT
We report a new assay of human delta-aminolevulinic acid dehydratase (ALAD), an enzyme converting delta-aminolevulinic acid (ALA) into porphobilinogen. The assay is developed for use in the clinical diagnosis of delta-aminolevulinic acid dehydratase-deficient porphyria, a rare enzymatic deficiency of the heme biosynthetic pathway. The assay involves the incubation of erythrocyte lysate with the natural substrate, ALA, followed by quantitative in situ conversion of porphobilinogen to its butyramide, and liquid-liquid extraction into a mass spectrometer-friendly solvent. Quantitation of the butyrylated porphobilinogen is done by electrospray ionization tandem mass spectrometry, using a deuterium labeled internal standard. The assay stays well within the range wherein ALAD activity is linear with time. The K(m) of ALAD for ALA was measured as 333 microM, and the V(max) was 19.3 microM/h. Average enzyme activity among a random sample of 36 anonymous individuals was 277 micromol/L erythrocyte lysate/hour with a standard deviation of 90 micromol/L erythrocyte lysate/hour. The tandem mass spectrometric assay should easily detect the enzyme deficiency, which causes a reduction of activity by 95-99%. The assay shows good reproducibility and low background, requires a simple workup, and uses a commercially available substrate.
Subject(s)
Heme/biosynthesis , Porphobilinogen Synthase/metabolism , Porphyrias/diagnosis , Spectrometry, Mass, Electrospray Ionization/methods , Tandem Mass Spectrometry , Aminolevulinic Acid/metabolism , Deuterium/chemistry , Erythrocytes/immunology , Erythrocytes/metabolism , Humans , Kinetics , Porphobilinogen/analysisABSTRACT
Photodynamic therapy (PDT) based on the photosensitive protoporphyrin IX (PpIX) may prevent restenosis after transluminal angioplasty. PpIX is synthesized in mitochondria, which differ in number and activity among various tissues. Therefore, we questioned whether the course of PpIX concentration after systemic aminolaevulinic acid (ALA) administration differed among various arteries. ALA was administered intravenously (200 mg/kg) to male Wistar rats (n = 21). At varying time intervals (0, 1, 2, 3, 6, 12 and 24 h) both central and peripheral arteries were isolated and homogenized, and the concentration of the various heme intermediates was determined by a fluorometric extraction method. The maximal PpIX concentration was more than two-fold higher in peripheral arteries (20.49 +/- 3.0 to 24.0 +/- 7.5 pmol/mg protein) than in central arteries (0-9.46 +/- 0.01 pmol/mg protein) (P < 0.004). However, the amount of citrate synthase, reflecting the mitochondrial mass, was lower (0.14-0.61 and 1.87-2.32 U/mg protein, respectively). Apparently, the level of PpIX cannot simply be explained by the mitochondrial content of the arteries. The time interval of maximal PpIX accumulation was similar in peripheral and central arteries (2 h and 27 min vs. 2 h and 8 min) (P = 0.13). Thus, if the efficacy of PDT in vivo is directly related to the tissue concentration of PpIX, more effect can be expected in peripheral arteries than in central arteries.
Subject(s)
Aminolevulinic Acid/pharmacology , Arteries/metabolism , Protoporphyrins/pharmacokinetics , Aminolevulinic Acid/analysis , Aminolevulinic Acid/blood , Animals , Arteries/ultrastructure , Male , Mitochondria/chemistry , Porphobilinogen/analysis , Porphobilinogen/blood , Protoporphyrins/blood , Rats , Rats, Wistar , Time FactorsABSTRACT
As porfirias são causadas por deficiência parcial de uma das enzimas da via de biossíntese do heme, caracterizando-se por disfunções neuroviscerais bastante semelhantes. As profirias agudas são decorrentes da deficiência das enzimas delta-aminolevulinato desidratase (ALAD), porfobilinogênio desaminase, coproporfirinogênio oxidase ou protoporfirinogênio oxidase, que provocam, respectivamente, porfiria por deficiência da ALAD, porfiria aguda intermitente, coproporfiria hereditária e porfiria variegada. Todas as porfirias agudas caracterizam-se por um aaumento na concentração de ácido 5-aminolevulínico no plasma e no líquor, acompanhado de um aumento na excreção urinária deste composto...
Subject(s)
Humans , Adult , Aminolevulinic Acid/analysis , DNA , Mutation/genetics , Porphobilinogen/analysis , Porphyria, Acute Intermittent , Porphyrins , Blood , Feces , Specimen Handling , UrineABSTRACT
Urine is the most frequent specimen used in the initial evaluation of adult patients who present with photosensitivity. When urine porphyrins are abnormal, characterization of the chromatogram is facilitated by calculation of uroporphyrin-to-heptacarboxylate porphyrin (uro/hepta) and uroporphyrin-to-isocoproporphyrin (uro/iso) ratios. The most frequent abnormal pattern, and that most consistent with porphyria cutanea tarda (PCT), is an uro/hepta ratio < or =2.0 and an uro/iso ratio < or =18. When the uro/hepta or uro/iso ratios are less consistent with PCT, other less common porphyrin disorders should be considered. These include variegate porphyria, coproporphyria with manifestations of photosensitivity only, adult onset congenital porphyria, mixed porphyrias, and other less frequent porphyrin disorders. After initial evaluation, the diagnosis should ideally be confirmed by additional testing of blood and fecal specimens. Most attacks of the acute porphyrias are associated with a uro/hepta ratio >4, and can be confirmed by an elevated urine porphobilinogen concentration.
Subject(s)
Chromatography, High Pressure Liquid/standards , Porphyria Cutanea Tarda/urine , Porphyrins/analysis , Porphyrins/urine , Humans , Photosensitivity Disorders/diagnosis , Photosensitivity Disorders/urine , Porphobilinogen/analysis , Porphobilinogen/urine , Porphyria Cutanea Tarda/diagnosis , Reference ValuesABSTRACT
Capillary electrophoretic simultaneous determination of a mixture containing delta-aminolevulinic acid, porphobilinogen, levulinic acid and glycine was investigated. With increases in the sodium tetraborate buffer concentration (5-70 mM), resolution of the four components was improved, but the migration time was increased. Alternatively, with increases in the applied voltage (5-22.5 kV), a shortened migration time was seen but this adversely affected resolution. The components were separated with high resolution by using a fused-silica capillary column (75 cm x 75 microm I.D.) filled with 30 mM sodium tetraborate buffer (pH 9.3-9.4) under the applied voltage of 20 kV (constant voltage mode). When the established method was applied to the culture broth of Rhodopseudomonas sphaeroides, a photosynthetic bacterium, the four components mentioned above were separated with good resolution. Furthermore, the use of this method would provide a fast, sensitive and specific method for monitoring the administration of delta-aminolevulinic acid in photodynamic cancer therapy, for the measurement of delta-aminolevulinic acid dehydratase activity in erythrocytes, and for testing the delta-aminolevulinic acid assay and for impurities in drug formulation.
Subject(s)
Aminolevulinic Acid/analysis , Culture Media/chemistry , Electrophoresis, Capillary/methods , Glycine/analysis , Levulinic Acids/analysis , Porphobilinogen/analysis , Calibration , Rhodobacter sphaeroides/chemistryABSTRACT
OBJECTIVES: To describe the biochemical and clinical features in hereditary coproporphyria (HCP). DESIGN AND METHOD: Within the last 20 years, we investigated 53 patients (male:female = 1:2.5; age = 8-86 years) suffering from HCP. We describe the characteristic levels of urine, and fecal porphyrins and their precursors in hereditary coproporphyria and present the clinical features. Especially, we measured the coproporphyrin isomers I and III. RESULTS AND CONCLUSION: The group of hereditary coproporphyria patients exhibited a significantly higher (p<0.0001) excretion of urinary porphyrin precursors, delta-aminolevulinic acid (median = 84 micromol/24 h) and porphobilinogen (median = 39 micromol/24 h), as compared to controls (delta-aminolevulinic acid: 22 micromol/24 h, porphobilinogen: 3 micromol/24 h; median, n = 20). The median of coproporphyrin in urine (1315 nmol/24 h) and feces (1855 nmol/g) were enhanced 12- and 168-fold, as compared to healthy subjects (urinary coproporphyrin: 106 nmol/24 h, fecal coproporphyrin: 11 nmol/g; median, n = 20). During therapy on one female patient, with IV application of heme arginate, a considerable decline of porphyrin precursors and porphyrin excretion was observed. The examination of urinary and fecal coproporphyrin isomers I and III revealed an excessive elevation of the coproporphyrin isomer III of 87% in urine and 94% in feces, respectively (normal: urinary isomer III = 69-83% and fecal isomer III = 25-40%). In feces the increase of isomer III caused an inversion of the physiologic coproporphyrin isomer III:I ratio that could be recognized in all various stages in hereditary coproporphyria and in children. Acute attacks of hereditary coproporphyria are accompanied by an acute polysymptomatic clinical syndrome, and this is associated with high levels of urinary porphyrin precursors. On review of our patients, the highest percentage had abdominal pain (89%), followed by neurologic (33%), psychiatric (28%), cardiovascular (25%), and skin symptoms (14%).
Subject(s)
Aminolevulinic Acid/analysis , Coproporphyrins/analysis , Feces/chemistry , Porphobilinogen/analysis , Porphyrias, Hepatic/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Aminolevulinic Acid/urine , Arginine/therapeutic use , Child , Chromatography, High Pressure Liquid , Coproporphyrinogen Oxidase/genetics , Coproporphyrins/urine , Female , Germany , Heme/therapeutic use , Heterozygote , Humans , Isomerism , Male , Middle Aged , Porphobilinogen/urine , Porphyrias, Hepatic/diagnosis , Porphyrias, Hepatic/drug therapy , Porphyrias, Hepatic/genetics , Uroporphyrins/analysis , Uroporphyrins/urineABSTRACT
A capillary zone electrophoresis/electrospray ionisation mass spectrometry (CZE/ESI-MS) method has been developed for the separation and detection of 5-aminolaevulinic acid (ALA) and porphobilinogen (PBG). Capillaries were 70 cm long with an inner diameter of 75 micrometer and outer diameter of 375 micrometer. The buffer used was aqueous ammonium acetate (50mM, pH 5.2) with a co-axial 'make-up' flow of methanol/aqueous 0.1% formic acid (1:1 v/v) at a flowrate of 6 microL/min. A voltage of 20 kV was used for CZE and an ESI voltage of 3.5 kV. Full scan data was acquired over the range m/z 100-500 in positive ion mode, from which selected ion electropherograms were extracted; at m/z 132 for the protonated molecular ion of ALA and m/z 210 for the methylenepyrrolenine fragment ion of PBG. The protonated molecular ion of PBG, m/z 227, was found to be too facile to monitor, easily losing ammonia in the electrospray source and better sensitivity was achieved by monitoring the resulting fragment ion. The detection limits were circa 100 attomoles of ALA and 10 attomoles of PBG at a signal-to-noise ratio (S/N) better than 10, providing sufficient sensitivity for clinical use and offering advantages over existing techniques.
Subject(s)
Aminolevulinic Acid/analysis , Porphobilinogen/analysis , Aminolevulinic Acid/chemistry , Electrophoresis, Capillary/methods , Mass Spectrometry/methods , Porphobilinogen/chemistry , Sensitivity and SpecificitySubject(s)
Hydroxymethylbilane Synthase/chemistry , Porphobilinogen/analysis , Amino Acid Sequence , Binding Sites , Coenzymes/analysis , Escherichia coli/enzymology , Hydroxymethylbilane Synthase/isolation & purification , Hydroxymethylbilane Synthase/metabolism , Molecular Weight , Point Mutation , Porphobilinogen/metabolismABSTRACT
Contrary to the belief that porphyrias are of relatively rare occurrence, there has recently been a rapidly increasing number of reported cases of the disease apparently as a result of growing interest of clinicians, the advance of biochemical and molecular biological research works and improvement and refinement of diagnostic techniques. Unfortunately, however, it is an unquestionable fact that porphyrias are not infrequently still misdiagnosed. Detection and identification of the porphyrias constitutes an important step in the treatment of the diseases and, accordingly, determination of porphyrins and their precursors is of paramount therapeutic importance. While porphyrins are normally detected in small amounts in healthy individuals, these compounds are excreted in large quantities in the urine or feces or both in hereditary and chemical porphyrias, owing to inborn errors in heme biosynthesis and in hemolytic anemia, as a result of excessive production, resulting from increased heme biosynthesis. It follows that determination of porphyrins and their precursors in clinical materials is of pivotal importance in establishing the diagnosis of porphyrias. This paper reviews the methods of determination of porphyrins and their precursors in clinical materials and techniques employed for this purpose.